Opportunity
SAM #HT941026N0059
Sole Source Procurement of Sysmex Hematology and Coagulation Analyzers for Osan Air Base, Korea
Buyer
Defense Health Agency
Posted
May 11, 2026
Respond By
May 21, 2026
Identifier
HT941026N0059
NAICS
334516, 423450
This opportunity involves a sole source procurement by the Defense Health Agency Contracting Activity (DHACA), Healthcare Contracting Division West (HCD-W), for the installation and implementation of Sysmex Hematology and Coagulation Analyzers at Osan Air Base, South Korea. - Sole source contract to SL MEDITECH CO, the exclusive importer and distributor for Sysmex analyzers and related consumables in Korea - Equipment includes Sysmex Hematology and Coagulation Analyzers, with all associated reagents, consumables, and technical support - Services include installation, implementation, and preventive maintenance of the analyzers - Delivery and installation are for the 51st Medical Group at Osan Air Base - Contract period includes a base year (delivery by September 30, 2027) and four annual option periods through September 30, 2031 - No other vendors are authorized to provide these products or services due to proprietary restrictions - The procurement is justified as Other Than Full and Open competition - Primary OEM is Sysmex; SL MEDITECH CO is the sole authorized distributor - Estimated contract value is not specified, but likely in the range of $500,000 to $2,000,000 based on typical analyzer procurements - Place of performance and delivery is Osan Air Base, South Korea; contracting office is at Camp Pendleton, CA
Description
Notice of Intent to Sole Source HT941026N0059
The objective of this sole source award is to procure equipment installation and implementation of fully functional Sysmex Hematology and Coagulation Analyzers for Osan Air Base, Korea. SL MEDITECH CO is the official importer of the Hematology Analyzers and Blood Coagulation Analyzerd for Sysmex and is proprietary with no authorized provider of this equipment, reagents and consumables, or technical support. There is no reasonable expectation of receiving quotes from two or more small businesses. The proposed acquisition strategy is to justify as an Other Than Full and Open procurement on a sole source basis.
See Attached NOI